WORK Competitors
| WOK Stock | 1.34 0.08 5.63% |
WORK Medical vs Jasper Therapeutics Correlation
Modest diversification
The correlation between WORK Medical Technology and JSPR is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding WORK Medical Technology and JSPR in the same portfolio, assuming nothing else is changed.
Moving together with WORK Stock
| 0.69 | BSX | Boston Scientific Corp Earnings Call Tomorrow | PairCorr |
Moving against WORK Stock
| 0.69 | IRMD | Iradimed | PairCorr |
| 0.67 | FIGS | Figs Inc | PairCorr |
| 0.5 | TNDM | Tandem Diabetes Care | PairCorr |
| 0.49 | LUCD | Lucid Diagnostics | PairCorr |
| 0.42 | NPCE | Neuropace | PairCorr |
WORK Medical Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between WORK Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of WORK and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of WORK Medical Technology does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between WORK Stock performing well and WORK Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze WORK Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| LIPO | 7.55 | (0.22) | 0.00 | (0.09) | 0.00 | 17.14 | 44.95 | |||
| SLRX | 6.68 | (1.84) | 0.00 | 0.93 | 0.00 | 16.00 | 61.05 | |||
| SLXN | 4.15 | (0.87) | 0.00 | (0.45) | 0.00 | 15.09 | 37.24 | |||
| INDP | 5.93 | (0.63) | 0.00 | (0.17) | 0.00 | 13.58 | 51.64 | |||
| PTIX | 7.06 | (2.05) | 0.00 | 0.94 | 0.00 | 14.81 | 58.73 | |||
| BIAF | 3.97 | (1.09) | 0.00 | (0.21) | 0.00 | 9.55 | 19.84 | |||
| SPRC | 4.10 | (2.24) | 0.00 | (2.72) | 0.00 | 3.57 | 30.69 | |||
| MNDR | 10.41 | (0.20) | 0.00 | 0.57 | 0.00 | 38.58 | 121.66 | |||
| ARTL | 5.34 | (0.71) | 0.00 | (0.70) | 0.00 | 7.86 | 43.34 | |||
| JSPR | 4.27 | (0.49) | 0.00 | 0.53 | 0.00 | 7.73 | 31.75 |
Cross Equities Net Income Analysis
Compare WORK Medical Technology and related stocks such as Lipella Pharmaceuticals, Salarius Pharmaceuticals, and Biomotion Sciences Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LIPO | (61.8 K) | (61.8 K) | (61.8 K) | (61.8 K) | (61.8 K) | (61.8 K) | (61.8 K) | (61.8 K) | (61.8 K) | (61.8 K) | (61.7 K) | (1.9 M) | (2.6 M) | (4.6 M) | (5 M) | (4.5 M) | (4.3 M) |
| SLXN | (195.9 K) | (195.9 K) | (195.9 K) | (195.9 K) | (195.9 K) | (195.9 K) | (195.9 K) | (195.9 K) | (195.9 K) | (195.9 K) | (195.9 K) | (755.2 K) | (3.2 M) | (4.9 M) | (16.4 M) | (14.8 M) | (14.1 M) |
| INDP | (5.4 M) | (7.6 M) | (5.2 M) | (5.1 M) | (5.7 M) | (7.2 M) | (13.4 M) | (28.9 M) | (43.5 M) | (47.6 M) | (3.6 M) | (7.7 M) | (14.3 M) | (15.4 M) | (15 M) | (13.5 M) | (14.2 M) |
| PTIX | (476 K) | (476 K) | (1 M) | (1.1 M) | (1.1 M) | (476 K) | (2.3 M) | (2.3 M) | (2.6 M) | (1.8 M) | (2.5 M) | (4.5 M) | (3.6 M) | (5 M) | (5.5 M) | (5 M) | (5.2 M) |
| BIAF | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (7.3 M) | (6.3 M) | (8.2 M) | (7.9 M) | (9 M) | (8.1 M) | (8.5 M) |
| SPRC | (1.7 M) | (3.7 M) | (3.5 M) | 59.4 K | (1.9 M) | (2.5 M) | (2 M) | (6.2 M) | (8.5 M) | (5.4 M) | (3.5 M) | (5.8 M) | (2.6 M) | (5.1 M) | (6.3 M) | (5.7 M) | (5.9 M) |
| MNDR | (460.2 K) | (460.2 K) | (460.2 K) | (460.2 K) | (460.2 K) | (460.2 K) | (460.2 K) | (460.2 K) | (460.2 K) | (460.2 K) | (460.2 K) | 68.2 K | (2.4 M) | (15.6 M) | (2.6 M) | (2.3 M) | (2.4 M) |
| ARTL | (15.3 K) | (15.3 K) | (15.3 K) | (15.3 K) | (15.3 K) | (15.2 K) | (29.7 K) | (234.9 K) | (2.3 M) | (2.2 M) | (4.7 M) | (7.4 M) | (10.1 M) | (9.3 M) | (9.8 M) | (8.8 M) | (8.4 M) |
| JSPR | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (31.7 M) | (30.6 M) | (37.7 M) | (64.5 M) | (71.3 M) | (64.1 M) | (67.3 M) |
WORK Medical Technology and related stocks such as Lipella Pharmaceuticals, Salarius Pharmaceuticals, and Biomotion Sciences Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in WORK Medical Technology financial statement analysis. It represents the amount of money remaining after all of WORK Medical Technology operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.WORK Medical Competitive Analysis
The better you understand WORK Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, WORK Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across WORK Medical's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
WORK Medical Competition Performance Charts
Five steps to successful analysis of WORK Medical Competition
WORK Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by WORK Medical Technology in relation to its competition. WORK Medical's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of WORK Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact WORK Medical's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to WORK Medical Technology, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your WORK Medical position
In addition to having WORK Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Emerging Markets Funds Thematic Idea Now
Emerging Markets Funds
Fund or Etfs that invest in markets of developing countries. The Emerging Markets Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out WORK Medical Correlation with its peers. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of WORK Medical. Anticipated expansion of WORK directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive WORK Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.95) | Earnings Share -2.8 K | Revenue Per Share | Quarterly Revenue Growth (0.14) | Return On Assets |
Investors evaluate WORK Medical Technology using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating WORK Medical's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause WORK Medical's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between WORK Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if WORK Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, WORK Medical's market price signifies the transaction level at which participants voluntarily complete trades.